Industries

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

Alembic’s New Gujarat Hub to Speed Up Medicine Supply

Alembic Pharmaceuticals Limited has marked a significant step forward in its logistics infrastructure with the launch of a new Central Stock Point (CSP) in Kheda,...

Mankind Pharma Announces Strategic Collaboration with Denovo Sciences to Advance AI-Driven Drug Discovery

Mankind Pharma Ltd, one of India’s leading pharmaceutical companies, announced a strategic collaboration with Denovo Sciences, a pioneer in artificial intelligence-driven therapeutics. This partnership...

Merck Group Inaugurates State-of-the-Art Global Capability Centre in Bengaluru

Merck Group has officially inaugurated its new, cutting-edge Global Capability Centre (GCC) in Electronic City, Bengaluru. Spanning an impressive 17,000 square metres, the integrated...

New Hope for Thyroid Eye Disease Treatment as FDA Approves Lumvoa

Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...

Not 100% Atta: FSSAI Slams ‘Eat Fit Digestive Biscuits’ for Deceptive Health Claims

The Food Safety and Standards Authority of India (FSSAI) has issued an official notice to SAJ Food Products following a consumer complaint regarding misleading labeling on...

GSK Launches Tender Offer to Acquire Precision Oncology Innovator Nuvalent, Inc.at $124.00

GSK plc has officially commenced a tender offer to acquire all issued and outstanding shares of Class A and Class B common stock of Nuvalent,...